| Identification | Back Directory | [Name]
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide | [CAS]
885126-35-2 | [Synonyms]
Axitinib Tetrahydro-2H-pyran
N-methyl-2-[1-(oxan-2-yl)-3-[(E)-2-pyridin-2-ylethenyl]indazol-6-yl]sulfanylbenzamide
6-(2-mercapto-N-methylbenzamide)-3-((E)
-2-pyridin-2-vinyl)-1-(tetrahydropyroan
-2yl)-1H-indazole
N-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl)thio)benzamide
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzamide
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide
Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]- | [Molecular Formula]
C27H26N4O2S | [MDL Number]
MFCD20486883 | [MOL File]
885126-35-2.mol | [Molecular Weight]
470.59 |
| Hazard Information | Back Directory | [Uses]
Axitinib Tetrahydro-2H-pyran is an intermediate in the synthesis of Axitinib (A794650). The Tetrahydro-2H-pyran moiety acts as a protecting group. |
|
|